Antiplatelet effects of aspirin vary with level of P2Y₁₂ receptor blockade supplied by either ticagrelor or prasugrel

J Thromb Haemost. 2011 Oct;9(10):2103-5. doi: 10.1111/j.1538-7836.2011.04453.x.

Authors

N S Kirkby, P D M Leadbeater, M V Chan, S Nylander, J A Mitchell, T D Warner

No abstract available

Publication types

Letter

MeSH terms

Adenosine / analogs & derivatives*
Adenosine / pharmacology
Aspirin / pharmacology*
Humans
Piperazines / pharmacology*
Platelet Aggregation Inhibitors / pharmacology*
Prasugrel Hydrochloride
Purinergic P2Y Receptor Antagonists / pharmacology*
Receptors, Purinergic P2Y12 / drug effects*
Thiophenes / pharmacology*
Ticagrelor

Substances

P2RY12 protein, human
Piperazines
Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Receptors, Purinergic P2Y12
Thiophenes
Prasugrel Hydrochloride
Ticagrelor
Adenosine
Aspirin